Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Nanomedicine (Lond). 2015 Jul;10(12):1881–1897. doi: 10.2217/nnm.15.37

Table 3.

Comparison of proportion of noninhibited complex between Z = 6 and Z = 1 when K = 1 but having equal drug targeting efficacy.

Substrate
targeting efficacy
(p)		 Proportion of
noninhibited
complex from
the population
with Z = 6		 Proportion of
noninhibited
complex from
the population
with Z = 1		 Ratio of the
proportions of
noninhibited complex
from the two
populations with Z = 6
and Z = 1		 Reduction (fold)
in proportion of
noninhibited complex
comparing Z = 6 and
Z = 1
0 1 1 1 1
0.1 0.5314 0.9 0.5905 1.7
0.2 0.2621 0.8 0.3277 3.1
0.3 0.117 6 0.7 0.16 81 5.9
0.4 0.0467 0.6 0.0778 12.9
0.5 0.0156 0.5 0.0312 32
0.6 0.0041 0.4 0.0102 98
0.7 7E-04 0.3 0.0024 416
0.8 1E-04 0.2 0.0003 3333
0.9 1E-06 0.1 1E-05 10,000